FDA Investigator: Kathryn E. Ogger
- Kathryn E. Ogger first started conducting FDA inspections in 2000, with the last inspection in 2001. Over that time, Kathryn E. Ogger has conducted 10 inspections at 9 companies across 9 sites.
Get Kathryn Ogger's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Erregierre S.p.A., San Paolo D'argon Bergamo | 2001
Out-of-stock
Kathryn E. Ogger
Human Drug Form 483
FDA 483 Bachem AG, Bubendorf | 2001
Out-of-stock
Kathryn E. Ogger
Human Drug Form 483
FDA 483 Reckitt Benckiser Healthcare (U.K.) Limited, Hull, East Yorkshire | 2001
Out-of-stock
Kathryn E. Ogger
Human Drug Form 483
FDA 483 Aventis Pharma Ltd., Holmes Chapel | 2000
Out-of-stock
Kathryn E. Ogger
Human Drug Form 483
FDA 483 Pfizer Ireland Pharmaceuticals Inc., Ringaskiddy, County Cork | 2000
Out-of-stock
Kathryn E. Ogger
Animal Drugs & Feed Form 483
FDA 483 Pfizer Ireland Pharmaceuticals, Ringaskiddy, Co. Cork | 2000
Out-of-stock
Kathryn E. Ogger
Human Drug Form 483
FDA 483 Caraco Pharmaceutical Laboratories, LTD., Detroit | 2000
Out-of-stock
Kathryn E. Ogger
Human Drug Form 483